BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30785523)

  • 1. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
    Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
    Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic role of serum interleukin-18 in gastric cancer patients.
    Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
    World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin-12 levels in patients with gastric cancer.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
    Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.
    Chan AO; Lam SK; Chu KM; Lam CM; Kwok E; Leung SY; Yuen ST; Law SY; Hui WM; Lai KC; Wong CY; Hu HC; Lai CL; Wong J
    Gut; 2001 Jun; 48(6):808-11. PubMed ID: 11358900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome.
    Galizia G; Lieto E; De Vita F; Romano C; Orditura M; Castellano P; Imperatore V; Infusino S; Catalano G; Pignatelli C
    J Interferon Cytokine Res; 2002 Apr; 22(4):473-82. PubMed ID: 12034030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Pentraxin-3, Interleukin-8 and Vascular Endothelial Growth Factor Levels in Patients with Gastric Adenocarcinoma.
    Yeni M; Korkut E; Aksungur N; Kara S; Askin S; Kartal M
    Asian Pac J Cancer Prev; 2021 May; 22(5):1507-1512. PubMed ID: 34048179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 levels reflect disease status of gastric cancer.
    Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
    Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary analysis of single-nucleotide polymorphisms in IL-10, IL-4, and IL-4Rα genes and profile of circulating cytokines in patients with gastric Cancer.
    Cárdenas DM; Sánchez AC; Rosas DA; Rivero E; Paparoni MD; Cruz MA; Suárez YP; Galvis NF
    BMC Gastroenterol; 2018 Dec; 18(1):184. PubMed ID: 30526523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
    Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
    Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-6 and -10 levels in patients with gastric cancer.
    Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S
    Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thymidine kinase is associated with gastric adenocarcinoma.
    Kemik O; Kemik AS; Purisa S; Tuzun S
    Bratisl Lek Listy; 2011; 112(9):510-1. PubMed ID: 21954529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of early intestinal dripping of jianpi tongli Chinese herbs on serum level IL-2, sIL-2R and IL-12 in patients with gastric cancer after operation].
    Yu QS; Liu Y; Hou Y; Zhang F; Yi W; Wang X; Shuai J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):710-3. PubMed ID: 16152828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
    Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
    J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-33 levels in patients with gastric cancer.
    Sun P; Ben Q; Tu S; Dong W; Qi X; Wu Y
    Dig Dis Sci; 2011 Dec; 56(12):3596-601. PubMed ID: 21643739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
    Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
    Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
    Xue T; Yang J; Song P; Zhou G
    J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.